Thermo Fisher subsidizes more sequencers for global coronavirus research

By The Science Advisory Board staff writers

January 14, 2021 -- Thermo Fisher Scientific is expanding a global SARS-CoV-2 program that provides its next-generation sequencers at subsidized prices to help analyze new strains of the virus and trace community transmission.

The company said that it set up the SARS-CoV-2 GlobalAccess Sequencing program in May with the goal of accelerating multi-institutional efforts at mapping coronavirus transmission and furthering understanding of disease epidemiology. Nowadays, the B.1.1.7 U.K. variant and other new strains of the virus are causing alarm.

The expansion involves the provision of additional units of the company's Ion Torrent Genexus System and Ion GeneStudio S5 sequencers, Thermo Fisher said.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?